Your browser doesn't support javascript.
loading
A phase I study of CAR-T bridging HSCT in patients with acute CD19+ relapse/refractory B-cell leukemia.
Ma, Yongyong; Zhang, Shenghui; Fang, Hongliang; Yu, Kang; Jiang, Songfu.
Afiliación
  • Ma Y; Department of Hematology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325000, P.R. China.
  • Zhang S; Department of Hematology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325000, P.R. China.
  • Fang H; R&D Department, Hrain Biotechnology Co. Ltd., Shanghai 200030, P.R. China.
  • Yu K; Department of Hematology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325000, P.R. China.
  • Jiang S; Department of Hematology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325000, P.R. China.
Oncol Lett ; 20(4): 20, 2020 Oct.
Article en En | MEDLINE | ID: mdl-32774493
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Oncol Lett Año: 2020 Tipo del documento: Article Pais de publicación: Grecia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Oncol Lett Año: 2020 Tipo del documento: Article Pais de publicación: Grecia